logo

Rocket Pharmaceuticals, Inc. (RCKT)



Trade RCKT now with
  Date
  Headline
4/14/2021 7:09:56 AM Rocket Reports Positive Long-Term Clinical Data From RP-L201 Trial For Leukocyte Adhesion Deficiency-I
3/29/2021 7:16:34 AM Rocket Pharma Gets EMA PRIME Designation For RP-L201 Gene Therapy For Treatment Of Leukocyte Adhesion Deficiency-I
9/2/2020 7:12:35 AM Rocket Pharmaceuticals Says First Patient Treated In Higher Dose Cohort In Phase 1 Clinical Trial Of RP-A501